CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RHHBY

Sefaxersen (RO7434656)

Phase 3
Roche Holding AG (RHHBY)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Aug '26
RHHBYPhase 3
Positive

Sefaxersen (RO7434656) Phase 3 Est. Readout

Sefaxersen (RO7434656)
Aug 2026~
CT.gov
Competitive Landscape

0 competitors in Primary IgA Nephropathy

View Full Landscape
Drug Information

Target Indication

Primary IgA Nephropathy

Clinical Trial

NCT05797610

Last updated: 2/9/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.